|
BD Biosciences to Collaborate With ReaMetrix in Development of Dried Reagents |
|
Tuesday, 02 February 2010 |
|
Limited access to laboratory testing facilities is one of the primary causes of improper CD4 monitering in managing HIV therapies in developing countries; one of the biggest challenges is dealing with a lack of adequate transport, storage and use of temperature-semsitive products and blood samples. A collaboration between BD Biosciences and ReaMetrix suggests an end to these concerns. As reported on medicalnewstoday.com on Jan. 14th, BD, along with ReaMatrix, announced plans to develop dried reagents for its BD FACSCount Flow Cytometry System which is widely used in the CD4 monitering of HIV/AIDS patients in developing countries. This development could eliminate the need for refrigeration, allowing more sites to offer CD4 counting.
|
|
Read more...
|
|
"Streptamer" Technology, Novel Approach to Cell Sorting, Characterizing |
|
Thursday, 21 January 2010 |
Lifescienceleader.com has reported Beckman Coulter, Inc.'s new addition of Streptamer Technology, a method of isolating and characterizing functional anitgen-specific T-cells by fluorescence-activated or magnet-assisted cell sorting manufactured by IBA GmbH, to their currrent product lines. This process is reversible which
leaves the isolated T-cells phenotypically and functionally
indistinguishable from untreated cells. This technology has the
potential to advance basic T-cell research as an essential prerequisite
for revolutionary immunological medicines.
|
|
Read more...
|
|
|
High Through-Put for a Faster Sequence |
|
Wednesday, 13 January 2010 |
|
Today Genomeweb.com announced Illumina's unveiling of a new genome sequencer which will allow researchers to sequence up to 11,000 human genomes per year. This sequencer has a second flow cell that allows a much higher through-put of information, but increases the cost for reagents. The hope is that this sequencer helps to bolster the sagging genome studies field.
|
|
Read more...
|
|
|
Shining a Light on Brain Behaviors |
|
Monday, 11 January 2010 |
As reported on January 6 on Forbes.com, Ed Boyden, a Neuroscientist at Massachusetts Institute of Technology, has discovered a way to use light to shut off portions of the brain in order to study behaviors associated with specific areas. The brain is reactivated once the light is turned off. Dr. Boyden has discovered a gene, that when introduced to the brain, instructs cells to pump protons when hit with a certain color of light, thereby changing the electrical charge of the cell and preventing it from sending signals. Dr. Boyden has yet to try it in humans due to the unknown adverse reactions of introducing this gene into the brain.
|
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
